Alexander Michael Leipold
0000-0002-9471-3276
Helmholtz Institute for RNA-based Infection Research
1 paper found
Refreshing results…
Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell–redirecting therapy
Missing publications? Search for publications with a matching author name.